Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment
August 7, 2020Medical Communications COVID, hydroxychloroquine
Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack …
AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China
August 7, 2020Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma
AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …
Trump signs executive order to direct federal agencies to prioritise purchasing drugs made in the US
August 7, 2020Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Peter Navarro, Trump, drug prices
US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug …
Top Ten most popular articles on Pharmafile.com this week
August 7, 2020Medical Communications COVID-19, Top 10 news, top 10
The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …
AstraZeneca’s Fasenra has strong Phase 3 showing in severe eosinophilic asthma
August 6, 2020Research and Development AstraZeneca, Fasenra, asthma
AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data …
Novartis’ Xolair scores European approval to treat chronic rhinosinusitis with nasal polyps
August 6, 2020Sales and Marketing Novartis, Xolair, rhinosinusitis
Novartis has snapped up approval from the European Commission for its anti-immunoglobulin E (IgE) antibody therapy Xolair (omalizumab) for the …
European Commission approves first drug for hepatitis D
August 6, 2020Business Services EC, hepatitis C, hepatitis D
The European Commission has approved Heplcudex (bulvirtide) as the first hepatitis D drug. It was jointly developed by researchers at …
US to pay Johnson and Johnson $1 billion for COVID-19 vaccine
August 6, 2020Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus
The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …
US Democrats probe Trump administration’s $765 million loan to Kodak to produce drug ingredients
August 6, 2020Business Services
Democratic members of Congress are set to investigate the Trump administration’s $765 million federal loan awarded to Kodak as it …
Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer
August 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …
NICE rejects mycosis fungoides-type cutaneous T-cell lymphoma therapy over data concerns
August 5, 2020Research and Development, Sales and Marketing Ledaga, NICE, lymphoma
NICE has announced its rejection of Ledaga (chlormethine gel), a topical therapy for the treatment of mycosis fungoides-type cutaneous T-cell …
NICE advises GPs to stop prescribing opioids for chronic pain
August 5, 2020Business Services, Research and Development COVID-19, coronavirus
The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …
EMA expands label for UCB’s Cimzia in axial spondyloarthritis
August 5, 2020Research and Development, Sales and Marketing Cimzia, EMA, Europe
The European Medicines Agency has expanded the existing approval of UCB’s Cimzia (certolizumab pegol) to cover the treatment of axial …
Pharmafile.com’s weekly COVID-19 news round-up
August 5, 2020Research and Development COVID-19, Weekly round up, coronavirus
The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …
Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis
August 5, 2020Research and Development, Sales and Marketing Coca-Cola, Coke
Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …
Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors
August 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …
VelosBio reveals new Chief Financial Officer
August 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment
Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …
Russia claims it will start mass immunisation with a COVID-19 vaccine from October
August 4, 2020Manufacturing and Production Russia, Vaccine, putin
The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …
Sanofi indicted on manslaughter charges over its epilepsy drug Depakine
August 4, 2020Manufacturing and Production Sanofi, Vaccine
Sanofi is being investigated for manslaughter in France over the deaths of four babies whose mothers took its anti-epilepsy medication …
UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns
August 4, 2020Manufacturing and Production UK, brexit, coronavirus
The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
